JA Pietenpol

968 citations
7 papers · 851 indexed · 1 hit paper · h-index 5

JA Pietenpol

7 papers receiving 836 citations

Hit Papers

Oncogenic forms of p53 inhibit p53-regulated gene expression8121992202620032014250500750

Peers

JA Pietenpol
Comparison fields: 5 of 54
  • Biotechnology 234
  • Oncology 719
  • Cancer Research 156
  • Molecular Biology 612
  • Genetics 88
Replace H W Stürzbecher with:
H W Stürzbecher United Kingdom
Loretta Raycroft United States
Sebastian Kehrloesser Germany
Troels S. Sørensen United Kingdom
Daniel Coutandin Germany
Rina Zakut-Houri Israel
Linghu Nie United States
Wilhelm Henning Germany
Natalie A Little Netherlands
Louise Aagaard Austria
JA Pietenpol relative to H W Stürzbecher United Kingdom H W Stürzbecher's profile →
Citations per field
00.5×1.7×
H W Stürzbecher · 1×
Citations per year

Countries citing papers authored by JA Pietenpol

Since Specialization
Citations

This map shows the geographic impact of JA Pietenpol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JA Pietenpol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JA Pietenpol more than expected).

Fields of papers citing papers by JA Pietenpol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JA Pietenpol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JA Pietenpol. The network helps show where JA Pietenpol may publish in the future.

Co-authorship network

The 22 scholars most cited alongside JA Pietenpol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with JA Pietenpol Line = papers co-authored together JA Pietenpol links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 201311
2 20122
3 20114
4 20101
5 20105
6 200916
7
Oncogenic forms of p53 inhibit p53-regulated gene expressionbreakdown →
1992812

About JA Pietenpol

JA Pietenpol is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 851 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), Cancer-related Molecular Pathways (4 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Treatment and Pharmacology (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), RNA modifications and cancer (1 paper), Breast Cancer Treatment Studies (1 paper) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Biotechnology (234 citations), Oncology (719 citations) and Cancer Research (156 citations). JA Pietenpol has collaborated with scholars based in United States. Frequent co-authors include S E Kern, Bert Vogelstein, Sam Thiagalingam, Kenneth W. Kinzler, A. E. Seymour, Yu Shyr, Julie Means‐Powell, IA Mayer, Johanna C. Bendell and Howard A. Burris. Their work appears in journals such as Science, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026